Board Changes

26 July 2023

WANdisco plc 

("WANdisco" or the "Company") 

Board Changes 

WANdisco (LSE: WAND), the data activation platform, announces a number of changes to the Board effective 25 July 2023 as follows:

· Stephen Kelly will join the Board as Chief Executive Officer having served as Interim Chief Executive Officer since 10 May 2023.

· Ijoma Maluza will join the Board as Chief Financial Officer having served as Interim Chief Financial Officer since 11 April 2023.

· Xenia Walters will join the Board as a Non-Executive Director and Chair of the Audit and Risk Committee.

· Chris Baker will join the Board as a Non-Executive Director and Chair of the Remuneration Committee.

· Karl Monaghan, Non-Executive Director and current Chair of the Audit and Risk Committee and the Remuneration Committee will step down from the Board ahead of the next Annual General Meeting in August.

· Yeturu Aahlad, Chief Scientist, will step down from the Board and will remain a member of the Executive Team.

Peter Lees will remain as Senior Independent Director and continue to be Chair of the Nomination Committee. Ken Lever remains as Non-Executive Interim Chairman. As previously announced, now that the refinancing has been completed and the share suspension has been lifted, a process will commence to identify a permanent Non-Executive Chair of the Board. Ken Lever will engage in that process.

Xenia Walters is a senior finance leader with an excellent track record of delivering operational and profit improvements within fast paced environments - both on the public markets and within private equity backed global operations. Xenia began her career with PriceWaterhouseCoopers (1991 to 1997) and during her career worked in various finance roles at Allied Colloids plc, Ciba Speciality Chemicals and Huntsman Chemicals. Xenia was with Regus plc from 2003 to 2011, initially as Group Financial Controller then as UK CFO. She was Group Finance Director of INTO University Partnerships and then Interim CFO of Oxford International Education Group until 2015, ultimately leading to her assuming the role of Group Chief Financial Officer of SDL plc and then Group CFO of Snowfox Group.

Chris Baker is an experienced leader in the international technology industry and currently a partner of CBCS Associates, a software advisory business. From 1983 to 1997 Chris was with Digital Equipment Company, rising to serve as UK Sales Director for Outsourcing. During the period 1997 to 2014, Chris held several senior roles within Oracle, rising to Senior Vice President and Worldwide Head of ISV/OEM/Java Sales. Chris was then Executive Director of Xchanging plc from 2014 to 2016, leading the Xuber Insurance Software business, and from 2016 to 2021 Chris was CEO of Capita Software.

Ken Lever, Interim Non-Executive Chairman, commented:

"Following the successful refinancing of WANdisco and the lifting of the share suspension, we are now able to formally shape the Board to support growth and value creation for shareholders. I am delighted that Chris and Xenia have agreed to join us at this very important juncture in the re-establishment of the Company as a leading business in the data-integration software market. I am very appreciative of the significant commitment shown by Karl and Aahlad to the Board's activities, especially during the very challenging times for the Company."

For further information, please contact:

About WANdisco

WANdisco is the data activation platform for accelerating digital transformation at scale. WANdisco makes infinite data actionable across clouds and enterprises in real time. WANdisco customers unleash the business value of the cloud with zero downtime, data loss, or disruption to fuel AI and machine learning, create new services, and transform businesses. For more information about WANdisco, visit www.wandisco.com

Regulatory disclosures

Stephen Paul Caulfield Kelly

The following information is provided pursuant to Rule 17 and with Schedule Two paragraph (g) of the AIM Rules for Companies in relation to Stephen Kelly (age 61):

As of the date of this announcement, Stephen Kelly holds a beneficial interest in 934,080 ordinary shares of the Company. Save as disclosed above there are no additional disclosures to be made in accordance with Rule 17 or Schedule Two paragraph (g) of the AIM Rules for Companies in respect of Stephen Kelly.

Ijoma Patrick Tilowakuti Maluza

The following information is provided pursuant to Rule 17 and with Schedule Two paragraph (g) of the AIM Rules for Companies in relation to Ijoma Maluza (age 44):

As of the date of this announcement, Ijoma Maluza holds a beneficial interest in 3,000 ordinary shares of the Company. Save as disclosed above there are no additional disclosures to be made in accordance with Rule 17 or Schedule Two paragraph (g) of the AIM Rules for Companies in respect of Ijoma Maluza.

Xenia Walters (maiden name Constantinou)

The following information is provided pursuant to Rule 17 and with Schedule Two paragraph (g) of the AIM Rules for Companies in relation to Xenia Walters (age 53):

As of the date of this announcement, Xenia Walters does not hold any beneficial interest in the ordinary shares of the Company. Save as disclosed above there are no additional disclosures to be made in accordance with Rule 17 or Schedule Two paragraph (g) of the AIM Rules for Companies in respect of Xenia Walters.

Christopher Francis Henry Baker

The following information is provided pursuant to Rule 17 and with Schedule Two paragraph (g) of the AIM Rules for Companies in relation to Chris Baker (age 67):

As of the date of this announcement, Chris Baker does not hold any beneficial interest in the ordinary shares of the Company. Save as disclosed above there are no additional disclosures to be made in accordance with Rule 17 or Schedule Two paragraph (g) of the AIM Rules for Companies in respect of Chris Baker.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.